NewEdge Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.96M | Sell |
67,179
-7,630
| -10% | -$865K | 0.03% | 567 |
|
|
2025
Q4 | $7.54M | Buy |
74,809
+53,797
| +256% | +$5.84M | 0.03% | 519 |
|
|
2025
Q3 | $2.59M | Buy |
21,012
+11,489
| +121% | +$1.43M | 0.01% | 888 |
|
|
2025
Q2 | $1.14M | Sell |
9,523
-2,741
| -22% | -$366K | 0.01% | 1212 |
|
|
2025
Q1 | $1.81M | Sell |
12,264
-1,183
| -9% | -$181K | 0.01% | 904 |
|
|
2024
Q4 | $2.18M | Buy |
13,447
+131
| +1% | +$21.4K | 0.01% | 798 |
|
|
2024
Q3 | $2.17M | Sell |
13,316
-3,431
| -20% | -$508K | 0.01% | 754 |
|
|
2024
Q2 | $2.29M | Buy |
16,747
+564
| +3% | +$78.3K | 0.02% | 697 |
|
|
2024
Q1 | $2.48M | Sell |
16,183
-822
| -5% | -$123K | 0.02% | 615 |
|
|
2023
Q4 | $2.43M | Sell |
17,005
-6,474
| -28% | -$863K | 0.02% | 599 |
|
|
2023
Q3 | $3.08M | Buy |
23,479
+6,776
| +41% | +$1.03M | 0.03% | 453 |
|
|
2023
Q2 | $2.66M | Sell |
16,703
-6,633
| -28% | -$1.07M | 0.03% | 500 |
|
|
2023
Q1 | $3.77M | Buy |
23,336
+6,398
| +38% | +$959K | 0.05% | 356 |
|
|
2022
Q4 | $1.7M | Buy |
16,938
+1,011
| +6% | +$143K | 0.05% | 362 |
|
|
2022
Q3 | $2.04M | Buy |
15,927
+2,303
| +17% | +$332K | 0.03% | 427 |
|
|
2022
Q2 | $1.92M | Sell |
13,624
-383
| -3% | -$54.7K | 0.03% | 446 |
|
|
2022
Q1 | $1.95M | Sell |
14,007
-3,465
| -20% | -$531K | 0.03% | 427 |
|
|
2021
Q4 | $3.05M | Buy |
17,472
+14,059
| +412% | +$2.34M | 0.05% | 337 |
|
|
2021
Q3 | $565K | Sell |
3,413
-57
| -2% | -$9.82K | 0.01% | 718 |
|
|
2021
Q2 | $624K | Buy |
3,470
+332
| +11% | +$60.6K | 0.02% | 675 |
|
|
2021
Q1 | $605K | Sell |
3,138
-995
| -24% | -$192K | 0.02% | 614 |
|
|
2020
Q4 | $835K | Sell |
4,133
-7,152
| -63% | -$1.48M | 0.03% | 462 |
|
|
2020
Q3 | $2.37M | Sell |
11,285
-2,599
| -19% | -$579K | 0.08% | 218 |
|
|
2020
Q2 | $3.05M | Sell |
13,884
-540
| -4% | -$108K | 0.12% | 173 |
|
|
2020
Q1 | $2.5M | Sell |
14,424
-2,672
| -16% | -$441K | 0.12% | 165 |
|
|
2019
Q4 | $2.62M | Buy |
17,096
+3,047
| +22% | +$455K | 0.1% | 197 |
|
|
2019
Q3 | $2.11M | Buy |
14,049
+11,018
| +364% | +$1.74M | 0.09% | 209 |
|
|
2019
Q2 | $464K | Sell |
3,031
-61,664
| -95% | -$9.42M | 0.03% | 414 |
|
|
2019
Q1 | $10.4M | Buy |
64,695
+62,893
| +3,490% | +$9.76M | 0.67% | 40 |
|
|
2018
Q4 | $278 | Sell |
1,802
-56
| -3% | -$8.72K | 0.02% | 506 |
|
|
2018
Q3 | $279K | Sell |
1,858
-284
| -13% | -$40.3K | 0.02% | 515 |
|
|
2018
Q2 | $286 | Sell |
2,142
-50
| -2% | -$6.17K | 0.03% | 421 |
|
|
2018
Q1 | $282K | Sell |
2,192
-40
| -2% | -$5.37K | 0.03% | 364 |
|
|
2017
Q4 | $327K | Sell |
2,232
-2
| -0.1% | -$272 | 0.04% | 299 |
|
|
2017
Q3 | $286K | Sell |
2,234
-293
| -12% | -$39.4K | 0.04% | 289 |
|
|
2017
Q2 | $337K | Sell |
2,527
-1
| -0% | -$135 | 0.06% | 240 |
|
|
2017
Q1 | $336K | Sell |
2,528
-27,564
| -92% | -$3.57M | 0.08% | 194 |
|
|
2016
Q4 | $3.58M | Sell |
30,092
-2,024
| -6% | -$239K | 0.99% | 38 |
|
|
2016
Q3 | $4.02M | Buy |
32,116
+12,301
| +62% | +$1.61M | 1.27% | 29 |
|
|
2016
Q2 | $2.75M | Buy |
19,815
+3,474
| +21% | +$450K | 1.14% | 34 |
|
|
2016
Q1 | $2.06M | Buy |
+16,341
| New | +$2.08M | 1.73% | 29 |
|
|
2015
Q3 | – | Sell |
-6,039
| Closed | -$628K | – | 54 |
|
|
2015
Q2 | $628K | Buy |
+6,039
| New | +$652K | 0.53% | 51 |
|
Other funds holding CLX
VCM
VPM
DAM
NewEdge Advisors's CLX Position: Q1 2026 in Review
NewEdge Advisors reduced its Clorox (CLX) stake by 10% in Q1 2026, selling an estimated $865K and leaving 67,179 shares worth $6.96M. The position accounts for 0.03% of the portfolio, ranked #567.
NewEdge Advisors first reported a position in CLX in Q2 2015 and has held it in 42 quarters since. The position peaked at $10.4M in Q1 2019. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- NewEdge Advisors held 67,179 shares of Clorox worth $6.96M as of Q1 2026.
- NewEdge Advisors sold 7,630 Clorox shares in Q1 2026, an estimated $865K.
- Clorox made up 0.03% of NewEdge Advisors's portfolio in Q1 2026, its #567 holding.
- NewEdge Advisors first reported a position in Clorox in Q2 2015 and has held it in 42 quarters since.
- NewEdge Advisors's Clorox position peaked at $10.4M in Q1 2019.
- 1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.